Bottom line
What is CBHCX's expense ratio?
CBHCX's expense ratio is 1.51%, or about $151 a year on every $10,000 invested. That is cheaper than 51% of alternatives funds we track (median 1.54%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Oct 27, 2026
CBHCX fee table
| Net expense ratio | 1.51% |
|---|---|
| Gross expense ratio | 1.8% |
| Management fee | 0.35% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.45% |
| Fee waiver / reimbursement | -0.29% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Oct 27, 2026
What CBHCX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| CBHCX | $254 | $538 | $948 | $1,820 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.51% expense ratio costs roughly $80,000 in lost growth, versus about $81,400 for the median alternatives fund (1.54%).